Publication | Open Access

Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study

Single-arm StudyPathologyPulmonary FibrosisMedicineCftr Gating Mutation